US Broker Ratings

Ultragenyx Pharmaceutical Inc. (RARE): Investor Outlook Shows a Potential 91% Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a pioneering entity in the biotechnology sector, has captured the attention of investors with its promising portfolio aimed at treating rare..

Sarepta Therapeutics (SRPT) Stock Analysis: Navigating the Biotech Waters with a Forward P/E of 7.64

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leading biotech firm, is making waves in the healthcare sector with its innovative RNA-targeted therapeutics and gene therapy solutions. As..

Oscar Health, Inc. (OSCR) Stock Analysis: Revenue Growth and Strategic Positioning Drive Investor Interest

Oscar Health, Inc. (NYSE: OSCR) is catching the eye of investors with its impressive revenue growth and strategic positioning in the healthcare plans sector. With a..

Cytokinetics, Incorporated (CYTK): Analyst Consensus Signals 59.78% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the biotechnology sector, captivating investor attention with its promise in muscle activator and inhibitor therapies. Headquartered in South San..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 175% Potential Upside in Biotech Innovation

Legend Biotech Corporation (NASDAQ: LEGN), a prominent player in the biopharmaceutical landscape, presents a compelling case for investors looking to capitalize on the burgeoning field of..

Atrium Therapeutics, Inc. (RNA)

⚠️ No article content returned.

..

Option Care Health, Inc. (OPCH) Stock Analysis: Strong Buy Ratings and a 17.63% Upside Potential

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector with its robust offerings in home and alternate site infusion services across the United..

RadNet, Inc. (RDNT) Stock Analysis: 24.51% Potential Upside as Diagnostic Imaging Innovator

As the healthcare industry continues to evolve, RadNet, Inc. (NASDAQ: RDNT) stands out as a key player in the diagnostics and research sector. With a market..

Regencell Bioscience Holdings (RGC): A Closer Look at Its Growth Potential and Market Position

Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based Traditional Chinese Medicine (TCM) bioscience company, is making waves in the healthcare sector with its focus on..

Rhythm Pharmaceuticals (RYTM): Analyst Consensus Points to 41.84% Upside Potential

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is making waves in the biotechnology sector with its promising portfolio of treatments for rare neuroendocrine diseases. With a market cap..

The Ensign Group, Inc. (ENSG) Stock Analysis: Exploring a 26.5% Potential Upside

Investors looking for opportunities in the healthcare sector should turn their attention to The Ensign Group, Inc. (NASDAQ: ENSG), a prominent player in the medical care..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating Challenges in the Medical Devices Sector

Bio-Rad Laboratories, Inc. (NYSE: BIO), a formidable player in the healthcare sector, has carved a niche for itself in the medical devices industry. Headquartered in Hercules,..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Look at Its 14.36% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is a rapidly growing player in the biotechnology sector, renowned for its focus on genetic medicines addressing diseases with high unmet..

Exelixis, Inc. (EXEL) Stock Analysis: Navigating Biotech with Strong Revenue Growth and Strategic Collaborations

Exelixis, Inc. (NASDAQ: EXEL), a prominent player in the biotechnology sector, is making waves with its innovative approaches to oncology treatments. Based in Alameda, California, Exelixis..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Potential 12.99% Upside Beckons Investors in the Healthcare Sector

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the healthcare sector known for its comprehensive eye health solutions, is drawing attention from investors with a..

Ionis Pharmaceuticals, Inc. (IONS): Investor Outlook on an 88.61% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leader in RNA-targeted therapies, is catching the attention of investors with its sizable potential upside of 88.61%. This commercial-stage biotechnology..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with a 7.15% Potential Upside

Lantheus Holdings, Inc. (LNTH), a formidable player in the healthcare sector, stands out in the niche of specialty and generic drug manufacturing. With a market capitalization..

Nuvalent, Inc. (NUVL) Stock Analysis: Navigating the Biotech Landscape with a Clinical Focus

Nuvalent, Inc. (NASDAQ: NUVL) has carved a niche in the promising and challenging field of biotechnology, specifically targeting cancer therapies. Despite its currently stable stock price..

Quest Diagnostics (DGX) Stock Analysis: Navigating the Diagnostic Giant’s Investment Landscape

Quest Diagnostics Incorporated (NYSE: DGX) stands out in the healthcare sector as a formidable player within the Diagnostics & Research industry. With a robust market capitalization..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating the Complex Terrain of Healthcare Innovation

Tempus AI, Inc. (NASDAQ: TEM), a pioneering entity in the healthcare technology sector, continues to chart an intriguing path in the health information services industry. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds